MedTrace Logo

Amphotericin B Treatment in Visceral Leishmaniasis

NCT00310505 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2008-09-12

No results posted yet for this study

Summary

This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.

Conditions

  • Visceral Leishmaniasis

Interventions

DRUG

Amphotericin B deoxycholate given as daily administration

Sponsors & Collaborators

  • Banaras Hindu University

    lead OTHER

Principal Investigators

  • Shyam Sundar, MD · Professor of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00310505 on ClinicalTrials.gov